Ireland· IE-PA-PA22650/004/001
Ultraproct 0.92 mg/g + 0.9 5mg/g + 5 mg/g Rectal Ointment
A fluocortolone product containing fluocortolone pivalate + fluocortolone caproate + cinchocaine hydrochloride, registered in Ireland by Karo Pharma AB. The same ATC class is registered in 4 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Fluocortolone is registered in 4 of 19 countries.
Countries holding a registration under ATC C05AA08 (fluocortolone), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 2 of them publish a price we can compare per daily dose
Fluocortolone · ATC C05AA08
4 / 19 countries
- Denmark
- Finlandprice
- Icelandprice
- Ireland
The record
At a glance
HPRA (Ireland)- Active substance
- Fluocortolone pivalate + Fluocortolone caproate + Cinchocaine Hydrochloride
- Manufacturer
- Karo Pharma AB
- Country
- Ireland (IE)
- ATC code
- C05AA08
- ATC class
- Fluocortolone
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA22650/004/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C05AA08
Fluocortolone, as other registers publish it.
- DenmarkDoloproct2care4 ApS
- DenmarkDoloproctKaro Pharma AB
- DenmarkDoloproctKaro Pharma AB
- IcelandDoloproctKaro Pharma AB*
- IcelandDoloproctKaro Pharma AB*
- DenmarkDoloproctAbacus Medicine A/S
- DenmarkDoloproctOrifarm A/S
- DenmarkDoloproctParanova Danmark ApS
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- France · Ultraproct
- Italy · Ultraproct
- Romania · Ultraproct
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2c1d56e-7449-49d7-a7db-478a99a5d665 GET /v1/drugs/f2c1d56e-7449-49d7-a7db-478a99a5d665?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Rectal ointment",
"routes": [
"Rectal use"
],
"source": "hpra",
"atc_all": [
"C05AA",
"C05AA08"
],
"strength": null,
"pa_number": "PA22650/004/001",
"substances": [
"Fluocortolone pivalate",
"Fluocortolone caproate",
"Cinchocaine Hydrochloride"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "01/04/1978",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about fluocortolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.